Filter
1411
Text search:
Rapid
Diagnostics
Featured
209
333
Language
Document type
559
318
259
104
90
41
13
12
5
3
3
2
1
Countries
87
66
37
34
29
24
24
23
23
21
21
21
21
20
20
19
19
18
17
16
13
12
12
12
11
11
10
8
8
8
8
8
7
6
6
6
5
5
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
448
152
73
62
51
24
15
Toolboxes
244
195
93
77
77
49
44
39
32
32
32
25
22
21
18
16
15
15
12
10
8
5
4
3
Towards the Peoples Health Assembly Book -1
THE REPUBLIC OF BOTSWANA | MINISTRY OF HEALTH | DEPARTMENT OF PUBLIC HEALTH | NATIONAL MALARIA CONTROL PROGRAMME
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Accessed November, 2017
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Policy statement.
The current document provides the background, justification and objectives for the revision of WHO policy on LF-LAM. It provides details on the index test (AlereLAM) being assessed. It also describes the process of evidence retrieval, quality assessment and grading; formulation of the recommendation
...
A survival guide for clinicans.
3rd edition.
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th
...
Lessons from the STEP-TB Project.
Accessed November 2017.
Information note.
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte ...
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte ...